Top Regulatory News Stories – Week Ending November 10, 2017

Hi folks.  I am posting a day early since I will be out of the office tomorrow.  The big news this week was the approval of a new molecular entity for Merck along with new indication approvals for both Genentech and Keryx. Here is my summary of the top stories this week: Merck announced that[…]